PRKN and type 2 diabetes mellitus: Zhao et al. revealed that NIPA2 increased osteoblast function, which was likely regulated by PTEN induced kinase 1/Parkin-mediated mitophagy in type 2 diabetes and osteoporosis (Zhao et al., 2020).